NOW FDA APPROVED for Lower Respiratory Tract Infections!
Curetis USA is focused on delivering fast, reliable and cost-effective molecular diagnostic solutions to aid in identifying severe infectious diseases. Now FDA approved for Lower Respiratory Tract Infections, Curetis’ Unyvero™ system provides U.S. clinicians with rapid and critical information for the early detection of microorganisms and their associated antibiotic resistance markers.
The Unyvero system is a sample-to-answer platform identifying 19+ microorganisms and 10 resistance markers. With this information, clinicians can confidently target treatment faster and improve outcomes.